WSJ. Magazine Celebrates Seventh Annual Innovator Awards
Nov 02, 2017 12:03 pm UTC| Business
NEW YORK, Nov. 02, 2017 -- WSJ. Magazine hosted its seventh annual Innovator Awards at the Museum of Modern Art in New York City last night. Seven trailblazing talents, all of whom are featured in the magazine’s highly...
VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum
Nov 02, 2017 12:02 pm UTC| Business
Ran Nussbaum, managing partner and co-founder of The Pontifax Group, joins VBI Board of DirectorsPontifax’s participation in the recent financing was alongside investments from several new fundamental life sciences...
Everspin To Announce Third Quarter 2017 Financial Results on November 13
Nov 02, 2017 12:02 pm UTC| Business
CHANDLER, Ariz., Nov. 02, 2017 -- Everspin Technologies, Inc., (Nasdaq:MRAM), today announced that it will report results for its fiscal third quarter 2017 after the market closes on Monday, November 13, 2017....
CASMED to Report Third-Quarter 2017 Financial Results and Hold Conference Call on November 9
Nov 02, 2017 12:02 pm UTC| Business
BRANFORD, Conn., Nov. 02, 2017 -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the third quarter...
Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule
Nov 02, 2017 12:02 pm UTC| Business
REHOVOT, Israel, Nov. 02, 2017 -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a unique computational predictive biology...
Attivo Networks® Expands Global Deception Technology Tour
Nov 02, 2017 12:02 pm UTC| Business
FREMONT, Calif., Nov. 02, 2017 -- Attivo Networks®, the award-winning leader in deception technology for cybersecurity defense, will continue the Attivo Networks Threat Defend™ Deception and Response Platform global...
PLx Pharma Inc. to Discuss 2017 Third Quarter Financial Results on November 10, 2017 Conference Call
Nov 02, 2017 12:02 pm UTC| Business
HOUSTON, Nov. 02, 2017 -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81...